Recruiting

Agnostic Therapy in Rare Solid Tumors

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(8 sites)

Brazil

Hospital São Carlos, Fortaleza, Ceará

Hospital São Rafael, Salvador, Estado de Bahia

Hospital Santa Cruz, Curitiba, Paraná

IDOR Recife, Recife, Pernambuco

Instituto D'or de Pesquisa e Ensino, São Paulo, São Paulo

Instituto do Câncer do Estado de São Paulo - ICESP, São Paulo, São Paulo

DF Star, Brasília

Instituto D'Or de Pesquisa e Ensino, Rio de Janeiro